Bill
Bill > SF4138
MN SF4138
MN SF4138Definition for covered insulin for the insulin safety net program and manufacturer registration fee provision
summary
Introduced
03/04/2026
03/04/2026
In Committee
03/04/2026
03/04/2026
Crossed Over
Passed
Dead
Introduced Session
94th Legislature 2025-2026
Bill Summary
A bill for an act relating to health; providing a definition for covered insulin for the insulin safety net program and manufacturer registration fee; amending Minnesota Statutes 2024, sections 13.381, subdivision 20; 151.74, subdivisions 1, 2, 3, 4, 5, 6, 7, 9, 10, 11, 13, 14; 151.741, subdivisions 1, 2; Minnesota Statutes 2025 Supplement, section 151.741, subdivision 5; repealing Minnesota Statutes 2024, section 151.74, subdivision 15.
AI Summary
This bill modifies the Minnesota Insulin Safety Net Program by defining "covered insulin" as any drug containing insulin prescribed by a practitioner for diabetes treatment, excluding those solely for intravenous infusion, and clarifies that manufacturers with less than $2 million in annual covered insulin revenue in Minnesota are exempt. It also establishes a manufacturer registration fee of $100,000 annually, with exemptions for manufacturers whose covered insulin sales represent less than five percent of the total market share in Minnesota, and amends provisions related to eligibility for urgent-need insulin, program access, manufacturer responsibilities, data privacy, reporting requirements, and program review, while also repealing a section related to program satisfaction surveys.
Committee Categories
Health and Social Services
Sponsors (1)
Last Action
Referred to Health and Human Services (on 03/04/2026)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.revisor.mn.gov/bills/94/2026/0/SF/4138/ |
| BillText | https://www.revisor.mn.gov/bills/94/2026/0/SF/4138/versions/0/pdf/ |
Loading...